“…The activity of GTS-21, NS6740, other α7 silent agonists, and allosteric modulators [1,15,17,32,34,56] in models of inflammatory disease and neuropathic pain appear to be independent of ion channel activation and, rather, depend on activation and modulation of intracellular signal transduction pathways [4,14,26,49,54]. In the case of the α7-mediated control of CAP, the cellular mediators of activity are themselves not even competent for generating nAChR channel currents, and so we must consider the complete receptor protein [50], multiple conformational states, and the complete receptor interactome [29,42] as mediators of the activity.…”